Purpose: Many techniques have been proposed to overcome the limitations displayed by maxillary atrophy. The aim of this systematic review was to assess the predictability, dimensional changes, and associated factors to successfully perform the alveolar ridge split (ARS) technique of augmentation. Materials and Methods: An electronic and manual literature searches was conducted by two independent reviewers in several databases, including Medline, Embase, Cochrane Central Register of Controlled Trials, and Cochrane Oral Health Group Trials Register, for articles written in English up to February 2014. A manual search was also performed to ensure a thorough screening process. Based on the PICO (problem, intervention, comparison, outcome) model, the chief question of this study was: Can patients with horizontal ridge de ciency be successfully treated with the ARS technique and implant therapy? Results: Overall, 17 articles met the inclusion criteria, and a subsequent meta-analysis was performed. A Cohen kappa interagreement rate of 0.82 was reached. The implant survival rate of the included studies was 97.0% (range, 94.4% to 100%) with the full-thickness ap (FTF) approach and 95.7% (range, 86.6% to 100%) with the partial-thickness ap (PTF) approach. The weighted mean (WM) of horizontal bone width gain was calculated for included studies using FTF for the ARS technique. Four studies that had data were included in the meta-analysis. The WM ± standard deviation of bone width gain was 3.19 ± 1.19 mm (range, 2.00 to 4.03 mm). For studies using PTF for ARS, only one study provided mean and standard deviation of horizontal bone width gain (4.13 ± 3.13 mm); hence, meta-analysis could not be performed. Buccal wall fracture represented the most frequent postoperative complication, followed by postoperative ridge resorption. Conclusion: In selected scenarios, the ARS technique might represent a predictable approach as demonstrated by a high implant survival rate, adequate horizontal bone gain, and minimal intra-and postoperative complications. Further research is needed to determine the in uence of the grafting materials inserted and ap tissue biotype, as well as the anatomical characteristics on nal bone augmentation outcomes. INT J ORAL MAXILLOFAC IMPLANTS 2015;30:596-606.
A lveolar bone resorption after tooth extraction often is a challenge for proper dental implant placement and stability, especially in the maxillary arch. [1] [2] [3] In maxillae, bone resorption after extraction follows a centripetal pattern; the majority of bone resorption occurs within the rst 6 months, and has been reported to be up to 40% in height and 60% in width. [4] [5] [6] [7] This translates to a horizontal bone resorption of 5 to 7 mm (50% of the original socket width), 8 which makes proper implant placement di cult.
Numerous treatment procedures/approaches have been proposed to overcome horizontal bone resorption. These include guided bone regeneration (GBR) using titanium mesh 9 or absorbable membrane, 10 bone blocks combined with or without particulate graft material, [11] [12] [13] [14] and the minimally invasive approach of using narrow-diameter implants. 15 All these approaches have been shown to be relatively predictable. 6 However, complications and drawbacks do exist. For example, membrane exposure to the oral cavity used for GBR might trigger infection, and as a consequence, lead to failure. 16 Furthermore, in case of bone block grafting, donor site morbidity might lead patients to look into other approaches. The alveolar ridge split (ARS) technique with or without the use of interpositional bone graft (also known as alveolar corticotomy) may overcome some of these de ciencies, while providing a good amount of dimension for proper implant insertion. 17, 18 ARS splits the crest cortical bone to create proper horizontal dimension for immediate or delayed implant placement. 19, 20 Advantages such as the possibility of simultaneous implant placement, avoiding donor site, reducing morbidity, and shortening the treatment time have all been associated with this approach. However, Scipioni et al 20 suggested using the partial-thickness ap (PTF) approach instead of the traditional full-thickness ap (FTF) approach to preserve periosteal blood supply and therefore minimize the amount of alveolar bone loss. Nonetheless, Blus et al 21 appealed for the traditional FTF approach because it is easier to control the surgical eld with the FTF approach.
Recently, Milinkovic and Cordaro conducted a systematic review to compare the e ectiveness of several techniques to augment horizontal bone in the atrophic maxillary ridges. 6 ARS was found to have a high implant survival rate (97.4%) with minimal technical complications (6.8%). However, factors that might in uence the outcomes were not addressed in that study. Hence, the present systematic review examined the amount of horizontal bone gain after ARS as well as its related predictability, complications, implant survival rate, and factors (eg, the FTF vs PTF approach) that might in uence the nal outcomes.
MATERIALS AND METHODS

Information Sources and Development of Focused Question
An electronic and manual literature searches were conducted by two independent reviewers (B.E. and A.M.) through the Medline, Embase, Cochrane Central Register of Controlled Trials, and Cochrane Oral Health Group Trials Register databases for articles written in English up to February 2014. Based on the PICO (problem, intervention, comparison, outcome) model, the chief question of the study was: Can patients with horizontal ridge de ciency be successfully treated with the ARS technique and implant therapy?
Screening Process
Two reviewers (AM and BE) designed and assessed the proposal for the present project to make sure the PRISMA guideline was followed to provide a high level of evidence. PRISMA consists of a 27-item checklist and a four-phase ow diagram. 22 Combinations of controlled terms (MeSH and Emtree) and keywords were used whenever possible. 
Eligibility Criteria
Articles were included in this systematic review if they met the following inclusion criteria: prospective or retrospective, cohort or case series with 10 or more human subjects, reporting the outcomes of ARS technique, implant survival and/or failure rate and/or mean and standard deviation of ridge gain, complication rates, horizontal bone augmentation in the partial or full edentulous maxilla. Accordingly, data on several factors, such as the study design, number of patients included at the last follow-up assessment, number of defect sites, surgical location, type of bone grafting material, whether a membrane was placed, implant system, and whether any other grafting material was further used (ie, growth factors), were extracted from the selected studies and analyzed. Moreover, to more comprehensively address the aim of this study, other parameters related to the technique were further extracted: initial mean bone ridge width, bone augmentation achieved at the end of the study period, mean resorption, and if failure occurred, the presumptive cause (Table 1) . Lastly, to study implant behavior on ridge-expanded bone, factors such as implant placement protocol, loading time, and cumulative survival rate were included in Table 1 . Case reports or case series with fewer than 10 subjects, systematic reviews, preclinical studies, or human trials with missing information were excluded. Also, studies in which ARS was followed by the use of expanders were further excluded to focus only on the most commonly used approach. References in the excluded articles were also screened for studies that met the inclusion criteria. The Newcastle-Ottawa scale (NOS) was used to assess the quality of such studies for a proper understanding of nonrandomized studies 23 by two calibrated masked investigators (B.E. and A.M.). The Cohen kappa coe cient was used to assess interrater agreement.
Data Analysis
The method of meta-analysis used for this article was previously described by another systematic review. 24 The primary outcome was the implant survival rate, and the secondary outcome was horizontal bone width gain. The pooled weighted mean (WM) and the 95% con dence interval (CI) of each variable were estimated using a computer program (Comprehensive Meta-analysis version 2, Biostat). Random e ects meta-analyses of the selected studies were applied to account for potential bias arising from methodologic di erences among studies. Forest plots were produced to graphically represent WM and 95% CI in primary/ secondary outcomes for included studies. The number of implants placed was used as the analysis unit for primary outcome; the number of defects was used as the analysis unit for secondary outcome. Funnel plots were also examined for publication bias. In addition, heterogeneity among studies was assessed with the chi-square test, with P < .05 representing signi cant heterogeneity. Regression analysis was also performed to analyze the potential impact of confounding factors, including the use of membrane or bone grafting materials, on primary and secondary outcomes. The ndings of these meta-analyses were reported in adherence to the Prisma statement. 25 
RESULTS
Study Selection
An initial screening yielded a total of 596 articles, of which 179 potentially relevant articles were selected after evaluation of their abstracts. Full texts of 30 articles were then obtained and reviewed. Of these, 17 articles met the inclusion criteria and subsequently were analyzed (Fig 1) . Articles with case reports or fewer than 10 subjects were excluded. 19, [26] [27] [28] [29] [30] In addition, six studies were excluded because data provided were inadequate. [31] [32] [33] [34] [35] [36] Eventually, one more study was excluded after contacting the corresponding author because it had been included in two consecutive publications. 21 This article was con rmed to have overlapping data and was excluded to avoid risk of bias. All the studies included were prospective [37] [38] [39] [40] [41] [42] [43] [44] [45] 
Study Quality
The NOS was used to appraise the quality of included studies for a proper understanding of nonrandomized studies. 23 Because no nonrandomized controlled trials were found in the screening process, the 17 included studies were analyzed with NOS. A Cohen kappa interagreement rate of 0.82 was reached (labeled as "almost perfect"). After discussing the disagreements between the examiners (B.E. and A.M.) and a third consultant (J.G.A.), a mean NOS score of 5.23 ± 1.77 was obtained.
Implant Survival Rate
Of the studies that used FTF elevation for ARS, 10 studies 37, 38, [42] [43] [44] [45] 47, [49] [50] [51] provided survival data and could be included in the meta-analysis. The WM of survival rate was 97.0% (range, 94.4% to 100%; 95% CI = 95.8% to 97.9%; Table 2 ). Using the chi-square test, P = .78, representing no statistically signi cant heterogeneity among studies. Using PTF for ARS, seven studies 20, [39] [40] [41] 46, 47, 52 provided survival data and could be included in the meta-analysis. The WM survival rate was 95.7% (range, 86.6% to 100%; 95% CI = 91.9% to 97.7%; Table 3 ). P = .43 with the chi-square test, which represented no statistically signi cant heterogeneity among studies.
Horizontal Bone Width Gain
The WM horizontal bone width gain was calculated for studies that used FTF for ARS. Four studies 44, 47, 49, 51 provided data and could be included in the meta-analysis. The WM bone width gain was 3.19 mm (range, 2.00 to 4.03 mm, with a 95% CI of 2.19 to 4.20 mm (Table 4) . P = .54 with the chi-square test, which represented low heterogeneity among studies. For studies using PTF for ridge splitting, only one study 47 provided mean and standard deviation of horizontal bone width gain (4.13 ± 3.13 mm); hence, that study could not be included in the meta-analysis.
Publication Bias
To investigate potential publication bias, the funnel plots of meta-analyses are shown in Fig 2a (primary  outcome, FTF), Fig 2b (primary outcome, PTF) , and Fig 2c (secondary outcome, FTF) . Full-text articles excluded (n = 13)
• No suf cient sample size (6) • No clear information (6) • Possible data overlapping (1) Records excluded (n = 417)
Additional records identi ed through other sources (n = 245)
Role of Grafting Material and/or Membrane Usage on Final Outcome
Two confounding factors, the use of bone grafting materials or membranes, were analyzed using metaregression. In the FTF group, the two confounding factors did not signi cantly in uence the primary outcome in any subgroup or combined analysis (P = . 35 for the use of bone grafting materials and P = .73 for the use of membrane). In the PTF group, the use of membranes was not considered as a confounding factor (P = .08). However, the use of bone grafting materials showed a signi cant di erence compared with nongrafting procedures (P < .0001; Fig 3) . 
Intra-and Postoperative Complications
Overall, eight articles reported the presence of complications. 20, 39, 40, [42] [43] [44] 47, 50 The reasons are described below and summarized in Table 5 .
• Bone fracture: Buccal wall fracture represented the most frequent postoperative complication. Ella et al 40 described 3-mm fractures in the crests of the buccal wall in 43% of cases. It was stressed that a narrower initial crest width increased the risk of fracture. Likewise, Sohn et al 50 reported ve fractures of the buccal wall with the FTF procedure. Two patients with the PTF procedure had buccal wall fracture, whereas lingual wall fracture occurred in one case of FTF. 47 Ferrigno et al 42 also noticed one fracture of the mandibular buccal plate. Rahpeyma et al, 44 on the other hand, reported one fracture of the lingual plate in the mandible at the time of implant placement (which did not extend beyond 5 mm in the apical direction). • Bone resorption: Ella et al 40 found that 47% of the crests displayed bone resorption around the implants and had a much higher resorption rate (25%) in the more narrow ridges (3 mm). Jensen et al 47 described facial bone loss of 2 mm or more in 11 sites, of which 10 had the FTF procedure. Demetriades et al 43 reported only one case of total full resorption in the FTF group. • Soft tissue recession: Jensen et al 47 found that 10 subjects had 2-to 3-mm recessions when undergoing FTF. Eight subjects who had PTF presented recessions of 2 mm. However, they reported only one case of 2-mm recession with a apless approach. • Prosthetic complications: Garcez-Filho et al 52 reported six cases of abutment screw loosening and two cases of ceramic fracture. In addition, Jensen et al 47 found two cases in which the implants were tilted, thus leading to esthetic disharmony. • Sensory disorders: Chiapasco et al 39 observed paresthesia in the region of the inferior alveolar nerve for 2 months in one subject and prolonged pain in the expanded area in another subject, which resolved spontaneously 1 month after surgery. Furthermore, Engelke et al 41 reported postoperative pain in four patients because of the presence of hydroxyapatite between the mucosa and the membrane.
DISCUSSION
Unavoidable bone resorption occurs after tooth extraction for which bone augmentation approaches must be used when opting for oral rehabilitation with dental implants. Indeed, a wide variety of studies have described successful outcomes with numerous techniques/approaches. It is important to note that regardless of the approach, vertical augmentation is still considered unpredictable. However, horizontal bone gain is considered foreseeable; nonetheless, the best approach to use will rely on the initial clinical presentation. Simultaneous GBR might be claimed when primary stability is achieved in the pristine bone, but it may have esthetic concerns. On the other hand, more traumatic treatment alternatives (ie, bone block grafting or ARS) exist, which aim to augment osseous tissues in the severely resorbed maxillary ridges. ARS is shown to be reliable when there is a minimal amount of cortical bone (≥ 1 mm) on both sides, with an existing trabecular region in between. Recently, Milinkovic and Cordaro 6 demonstrated that a mean implant survival rate of 97.4% could be obtained with minimal technical complications when using ARS. Our ndings agreed with their results. We found that regardless of the approach (FTF vs PTF), ARS is a predictable technique (> 95.7% implant survival rate) to augment bone horizontally within the range of 3.19 to 4.13 mm, depending on the approach (Fig 4 and Table 6 ). In addition, the implant survival rate was found to be high. This was shown to be statistically indistinct for PTF (95.7%) vs FTF (97%). Our hypothesis indicates that this slight di erence might be attributed to the reduced visibility when performing a PTF. Strikingly, Engelke et al 41 showed the highest failure rate (13.3%). This higher failure rate may be attributed to the PTF approach that they adopted. In addition, the study was conducted in 1997, when the technique was premature.
With the improvements in the technique and implant surfaces, survival rates in both groups are much higher. In fact, survival rates obtained in the present study are within the standards for success in implant dentistry. 53, 54 FTF re ection induces surface bone resorption and delayed bone repair. In other words, a PTF may preserve blood supply and thus achieve more bone gain and less bone resorption. However, Wood et al 55 found that crestal bone resorption could be minimized with FTF (0.62 mm) compared with PTF (0.98 mm). Nonetheless, owing to the small sample size, these ndings cannot be reliably extrapolated. Sta leno 56 showed that the osteoclast activity is higher and collagen content is lower in FTF and hence, more bone resorption might be expected. Because of this high variability of ndings among studies, the authors could not carry out a statistical analysis to compare both groups. Later, Jensen et al 47 in a retrospective cohort human study compared the horizontal bone gain achieved with both the FTF and PTF approaches. Results showed higher bone gain in the PTF group (4.13 ± 3.13 mm) compared with the FTF group (3.19 ± 1.19 mm). However, that study had only one individual in the PTF group, so the results must be interpreted cautiously. Recently, a study using a miniature pig model showed that 12 weeks after ARS, the buccal bone thickness in the mucosal ap group was 0 mm at implant shoulder and 2.56 mm at 4 mm apical to the same mark. 57 Keeping in mind the aforementioned studies, it is interesting to note that by re ecting FTF, the clinician is able to overbuild the outer cortical layer, which has been found to be very bene cial in horizontal bone gain. 58 This recon rmed the study of Jensen et al , 47 who also suggested that the FTF approach is more important for the initial ridge width of < 4 mm. Biomaterials have been shown to be e ective in assisting the process of GBR. 59, 60 Although bone substitutes such as xenogeneic grafts act as sca olds for osteogenic cell migration, some allogeneic grafts (ie, demineralized freeze-dried bone allografts) osteoinduce bone formation. 61 In addition to these grafting materials, numerous biologic agents (ie, bone morphogenetic proteins or platelet-rich plasma) demonstrated acceleration of the di erent stages of bone healing. 62 Accordingly, the ndings of the present study showed that implant survival rate for PTF is improved when the void spaces are lled out with grafting materials. Likewise, owing to the high heterogeneity, it was not possible to perform a meta-analysis of the in uence of material type on any of the outcomes studied. However, as pointed out earlier, placement of grafting material may assist in preserving/building three-dimensional bone morphology. 63 Interestingly, the present study did not nd any bene cial e ect of membrane placement during ARS, regardless of whether they used the FTF or PTF approach. Again, high heterogeneity was found in the studies analyzed.
Milinkovic and Cordaro 6 reported a complication rate of 6.8%, with buccal wall fracture being the most frequent. Likewise, the present systematic review showed wall fracture (either the buccal or the lingual) to be the most prevalent intraoperative complication. Ella et al 40 showed that the vast majority of fractures occurred in crests narrower than 3 mm. Henceforth, if at least 1 mm of the spongiosa is not present between both cortical layers, a complete buccal wall fracture is more likely to occur. 47 Therefore, the ARS approach should be reserved only for ridges with a minimum diameter of 3 mm to minimize fracture incidence. Nonetheless, if a fracture is noted, it can be corrected by xing the fracture plates with xation screws. 21 A factor that typically is not studied is the ridge shape. In this sense, if the base of the crest is narrow (< 3 mm) or if the walls have an "hourglass" morphology, a di erent approach should be considered because of the high incidence of wall fracture associated with this procedure. Lastly, but not of minor importance, is the implant geometry; a tapered-shape implant should be slightly better than the parallel design to not only minimize the fracture incidence but also achieve higher primary stability. 
Future Directions
Although ARS for horizontal bone augmentation is a widely studied technique, more clinical trials should be conducted to investigate the factors that may increase the predictability of this approach. An example is to study the in uence of ap re ection on ridge dimensions using digital images. It is worthwhile to explore the in uence of grafting materials and use of membranes in conjunction with the ARS. The biologic behaviors of these materials could be studied further; thus far, only one clinical research included histologic analysis. 30 As a matter of fact, ARS might represent a potential model for studying grafting materials in a sealed cavity. With recent advances in tissue engineering for regenerative medicine, [64] [65] [66] the application of di erent growth factors and biologics into customized sca olds and carriers for ARS will possibly be another future research eld.
CONCLUSIONS
In selected scenarios, ARS might be considered a predictable approach that demonstrates a high implant survival rate, adequate horizontal bone gain, and minimal intra-and postoperative complications. Further research is needed to determine the in uence of grafting materials inserted, ap tissue biotype, and the anatomical characteristics on nal bone augmentation outcomes.
